|1.||Niki, Etsuo: 1 article (01/2010)|
|2.||Cynshi, Osamu: 1 article (01/2010)|
|3.||Tamura, Kunio: 1 article (01/2010)|
|4.||Singh, V: 1 article (07/2008)|
|5.||Barthwal, M K: 1 article (07/2008)|
|6.||Tiwari, R L: 1 article (07/2008)|
|7.||Meng, Charles Q: 1 article (03/2003)|
|8.||Kodama, T: 1 article (01/2001)|
|9.||Suzuki, H: 1 article (01/2001)|
|10.||Kamada, N: 1 article (01/2001)|
01/01/2001 - "Thus, for C57BL/6J in the setting of prolonged exposure to a high-fat diet, defect of SR-A I/II expression is significantly protective against the development of atherosclerosis, as is the synthetic anti-oxidant BO-653. "
03/01/2003 - "BO-653 is an antioxidant under development by Chugai for the potential treatment of atherosclerosis and the prevention of restenosis. "
01/01/2001 - "The effects of SR-A I/II deficiency and a synthetic anti-oxidant BO-653 on a diet-induced atherosclerosis in C57BL/6J, an inbred strain known to be susceptible to diet-induced atherosclerotic lesion formation, were examined. "
08/18/1998 - "In atherosclerosis models of rabbits and mice, BO-653 has been shown to be able to suppress the formation of atherosclerotic lesions without untoward side effects. "
11/01/1997 - "It was concluded that BO-653 protected LDL from oxidative modification efficiently by scavenging peroxyl radicals and by reducing alpha-tocopheroxyl radicals and that this novel antioxidant might act as a potent inhibitor of development of atherosclerosis."
|2.||aniline (aniline hydrobromide)
|3.||succinobucol (AGI 1067)